Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease

NCT01864655 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: saracatinib
DRUG: Placebo

Sponsor

Stephen M. Strittmatter

Collaborators

[object Object]